Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 14, pseudogene (RN7SL14P)

Target
RN7SL14P
Molecular classification
Pseudogene, Non-coding RNA pseudogene
01

Overview

RN7SL14P (RNA, 7SL, cytoplasmic 14, pseudogene) is a nonfunctional genomic sequence classified as a pseudogene. Pseudogenes are DNA sequences similar to known genes but rendered nonfunctional by mutations or truncations. RN7SL14P derives from the 7SL RNA gene, which encodes the RNA component of the signal recognition particle (SRP), critical for ribosome-mediated protein targeting to the endoplasmic reticulum[2][3][7]. Unlike the active gene, RN7SL14P is truncated, not expressed at functional levels, and does not encode any protein or active RNA product. Most pseudogenes, including RN7SL14P, do not participate in regulatory or signaling processes and are not targets for drugs or disease-modifying interventions[1][2][4]. Occasionally, pseudogenes elsewhere in the genome can be transcribed at low levels or impact regulation, but no such evidence is found for RN7SL14P[1][2][4].

Other names
RN7SL14P
02

Mechanism of action

None applicable; no drugs act on this molecule

03

Biological functions

None directly; as a pseudogene, RN7SL14P does not have distinct biological functions. Functional 7SL RNA contributes to SRP-mediated protein targeting[2][3][7], but RN7SL14P lacks this activity.
04

Disease associations

None; no disease associations or roles have been reported for RN7SL14P[1]
05

Safety considerations

None; as a pseudogene, it does not pose safety or therapeutic challenges
06

Interacting drugs

None; no drugs target RN7SL14P due to its non-functional status
07

Biomarkers

None; RN7SL14P is not utilized as a biomarker for clinical purposes

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 14, pseudogene (RN7SL14P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 14, pseudogene (RN7SL14P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call